Remy Sukhija
2020
In 2020, Remy Sukhija earned a total compensation of $3.4M as Senior Vice President, Chief Commercial Officer at Synta Pharmaceuticals.
Compensation breakdown
| Bonus | $100,000 |
|---|---|
| Non-Equity Incentive Plan | $274,680 |
| Option Awards | $2,724,000 |
| Salary | $337,500 |
| Other | $2,722 |
| Total | $3,438,902 |
Sukhija received $2.7M in option awards, accounting for 79% of the total pay in 2020.
Sukhija also received $100K in bonus, $274.7K in non-equity incentive plan, $337.5K in salary and $2.7K in other compensation.
Rankings
In 2020, Remy Sukhija's compensation ranked 3,375th out of 13,090 executives tracked by ExecPay. In other words, Sukhija earned more than 74.2% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 3,375 out of 13,090 | 74th |
Division Manufacturing | 1,314 out of 5,624 | 77th |
Major group Chemicals And Allied Products | 499 out of 2,257 | 78th |
Industry group Drugs | 433 out of 1,957 | 78th |
Industry Pharmaceutical Preparations | 324 out of 1,462 | 78th |
Source: SEC filing on May 2, 2022.
Sukhija's colleagues
We found four more compensation records of executives who worked with Remy Sukhija at Synta Pharmaceuticals in 2020.